Clinical Trials in Boston

Showing 5841-5860 of 17,836 trials

Biomarkers to Predict Time to Plasma HIV RNA Rebound

NCT03001128

The purpose of this study is to collect information about what happens when people pause, or temporarily stop taking, ART, and to collect blood samples from these people at frequent intervals. We will also study the safety of pausing ART under close observation.

HIV-1 Infection

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections61 participantsStarted Feb 2017

Los Angeles, California, United States • San Diego, California, United States • San Francisco, California, United States +15 more locations

COMPLETEDPhase 2< 1 mile

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

NCT01889238

The purpose of this study is to determine if enzalutamide is safe and effective in the treatment of patients with advanced breast cancer that express the androgen receptor but do not express the estrogen or progesterone receptor and are not Her2 amplified.

Advanced, Androgen Receptor Positive Triple Negative Breast Cancer

Pfizer118 participantsStarted Jun 2013

Colorado Springs, Colorado, United States • Lakewood, Colorado, United States • Lone Tree, Colorado, United States +129 more locations

Biomarkers to Predict Time to Plasma HIV RNA Rebound

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

Find Trials by Condition in Boston

Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia

Magnetic Resonance Spectroscopic and Diffusion Tensor Imaging of Adolescents with Autism Spectrum Disorders

Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma

Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

Comprehensive Outcomes for After Cancer Health

A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)

Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia

AAV Gene Therapy Study for Subjects with PKU

Risk of Recurrent CeAD After Pregnancy

Honest, Open, Proud for Soldiers with Mental Illness